![Alliance for Regenerative Medicine Logo](https://alliancerm.org/wp-content/uploads/2018/05/arm_logo_white_text.png)
Armatus Bio, Inc.
Armatus Bio is a preclinical stage company pioneering RNA interference gene therapies for neuromuscular diseases. Our lead assets are AAV delivered miRNA therapies for Charcot-Marie-Tooth Type 1A (CMT1A) and facioscapulohumeral muscular dystrophy (FSHD). |